A carregar...
Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease
First developed for clinical use in the late 1980s, the phosphodiesterase inhibitors were found to increase the levels of the ubiquitous second messenger cyclic adenosine monophosphate and could effect changes invasculartone, cardiac function, and other cellular events. After several early studies u...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654250/ https://ncbi.nlm.nih.gov/pubmed/12058787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960250603 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|